|Bid||8.10 x 4000|
|Ask||8.10 x 29200|
|Day's range||7.94 - 8.26|
|52-week range||7.10 - 12.20|
|Beta (5Y monthly)||1.41|
|PE ratio (TTM)||4.61|
|Forward dividend & yield||0.33 (4.22%)|
|Ex-dividend date||03 Mar 2022|
|1y target est||8.91|
Barclays said on Monday it had identified a single "material weakness" in its internal control processes, as it refiled its accounts with U.S. regulators after a blunder led it to issue more structured notes than it was allowed. The bank disclosed earlier this year that it had to refile an accounting statement known as a form 20-F with the Securities and Exchange Commission because it had sold more structured notes than permitted in the United States. Barclays' statement on Monday appeared to confirm media reports that the problem related to accidental over-issuance of the securities because the bank had forgotten or disregarded regulatory limits.
The warning on Friday comes despite house prices increasing at double-digit rates in 2022.
(Bloomberg) -- Metropolis Healthcare Ltd., a diagnostics chain operating in India and Africa, is looking to raise more than $300 million and bring onboard a strategic partner by selling a significant minority stake, according to people familiar with the matter.Most Read from BloombergBroadcom in Talks to Acquire Cloud Company VMwareStocks Climb in Risk-On Day While Bonds Decline: Markets WrapBiden Misspeaks on Taiwan, Says US Military Would InterveneWalmart’s Troubles Should Have Everyone on Hig